SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
04-Jun-24 4:39 PM View: | Regenxbio Inc. (RGNX) | 31-May-24 | Grant | 4,790 | -- | -- | 74% 6.5K to 11.29K | |
22-May-24 4:33 PM View: | MacRogenics Inc (MGNX) | 20-May-24 | Option Exercise | 4,500 | -- | -- | 100% 0 to 4.5K | |
06-Jun-23 10:00 PM View: | Regenxbio Inc. (RGNX) | 02-Jun-23 | Grant | 3,486 | -- | -- | 116% 3.01K to 6.5K | |
07-Jun-22 4:22 PM View: | Regenxbio Inc. (RGNX) | 03-Jun-22 | Grant | 3,010 | -- | -- | 100% 0 to 3.01K | |
02-Jul-20 4:40 PM View: | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 20,475 | $18.00 | $368,550.00 | (100%) 20.48K to 0 | |
15-Jun-20 7:15 PM View: | Portola Pharmaceuticals Inc (PTLA) | 12-Jun-20 | Grant | 7,281 | -- | -- | 55% 13.19K to 20.48K | |
17-Jun-19 5:36 PM View: | Portola Pharmaceuticals Inc (PTLA) | 13-Jun-19 | Grant | 4,194 | -- | -- | 47% 9.0K to 13.19K | |
08-Jun-18 6:23 PM View: | Portola Pharmaceuticals Inc (PTLA) | 08-Jun-18 | Grant | 3,000 | -- | -- | 50% 6.0K to 9.0K | |
19-Jun-17 6:20 PM View: | Portola Pharmaceuticals Inc (PTLA) | 16-Jun-17 | Grant | 3,000 | -- | -- | 100% 0 to 3.0K | |
20-Jun-16 3:45 PM View: | Portola Pharmaceuticals Inc (PTLA) | 17-Jun-16 | Grant | 3,000 | -- | -- | 100% 0 to 3.0K | |
07-Jan-14 3:09 PM View: | Dendreon Corp. (DNDN) | 03-Jan-14 | Grant | 25,000 | -- | -- | 44% 57.05K to 82.05K | |
07-Jan-13 5:05 PM View: | Dendreon Corp. (DNDN) | 03-Jan-13 | Grant | 25,000 | -- | -- | 78% 32.05K to 57.05K | |
01-Aug-12 11:53 AM View: | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 68,701 | $14.25 | $978,989.00 | (78%) 88.28K to 19.58K | < 1% |
01-Aug-12 11:53 AM View: | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 19,576 | $14.25 | $278,958.00 | (100%) 19.58K to 0 | < 1% |
26-Jul-12 9:00 AM View: | Human Genome Sciences Inc. (HGSI) | 24-Jul-12 | Option Exercise | 68,701 | $6.20 | $426,266.00 | 351% 19.58K to 88.28K | |
05-Jan-12 6:43 PM View: | Dendreon Corp. (DNDN) | 03-Jan-12 | Grant | 25,000 | -- | -- | 355% 7.05K to 32.05K | |
24-Jan-11 8:09 PM View: | Dendreon Corp. (DNDN) | 20-Jan-11 | Grant | 3,507 | -- | -- | 99% 3.54K to 7.05K | |
04-Jun-10 6:36 PM View: | Dendreon Corp. (DNDN) | 02-Jun-10 | Grant | 3,540 | -- | -- | 100% 0 to 3.54K | |
01-Apr-10 3:49 PM View: | Human Genome Sciences Inc. (HGSI) | 01-Apr-10 | Option Exercise | 34,000 | $12.56 | $427,040.00 | 174% 19.58K to 53.58K | |
01-Apr-10 3:49 PM View: | Human Genome Sciences Inc. (HGSI) | 01-Apr-10 | Market Option Sale (Planned) | 34,000 | $30.72 | $1,044,370.00 | (63%) 53.58K to 19.58K | 21% |
02-Mar-10 1:15 PM View: | Human Genome Sciences Inc. (HGSI) | 01-Mar-10 | Option Exercise | 50,000 | $12.56 | $628,000.00 | 255% 19.58K to 69.58K | |
02-Mar-10 1:15 PM View: | Human Genome Sciences Inc. (HGSI) | 01-Mar-10 | Market Option Sale (Planned) | 50,000 | $28.07 | $1,403,700.00 | (72%) 69.58K to 19.58K | 14% |
02-Feb-10 5:17 PM View: | Human Genome Sciences Inc. (HGSI) | 02-Feb-10 | Option Exercise | 50,000 | $12.56 | $628,000.00 | 255% 19.58K to 69.58K | |
02-Feb-10 5:17 PM View: | Human Genome Sciences Inc. (HGSI) | 02-Feb-10 | Market Option Sale (Planned) | 50,000 | $27.40 | $1,370,020.00 | (72%) 69.58K to 19.58K | 12% |
23-Sep-08 2:57 PM View: | Human Genome Sciences Inc. (HGSI) | 23-Sep-08 | Disposition | 30,000 | -- | -- | (61%) 49.58K to 19.58K | |
23-Sep-05 11:37 AM View: | Human Genome Sciences Inc. (HGSI) | 21-Sep-05 | Grant | 45,000 | -- | -- | 983% 4.58K to 49.58K |